Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Amphion lifted by promissory note conversion at assumed 8p per share

The company issued 1.66mln shares to the loan note holder
Pound notes
Amphion's coffers were swollen by £133,173

Amphion Innovations Plc (LON:AMP), the developer of medical, life science, and technology businesses, has received £133,173 through the conversion of promissory notes.

The company issued 1.66mln shares, representing 0.8% of the enlarged share capital, to the loan note holder.

The notes were converted at a price of 8p per share, prompting market makers to bump up the Amphion share price from 1.37p overnight to 1.85p.

View full AMP profile View Profile

Amphion Innovations Plc Timeline

Related Articles

Tekcapital-Invention-Discovery-Network-(IDN)-June-2015_opt.jpg
July 31 2017
The firm has established connections with more than 4,000 universities in 160 countries enabling it to capture all of the intellectual property available
1505724201_learningtechnology.jpg
September 18 2017
Broker Numis thinks the benefits of the NetDimensions deal will be felt in the fourth quarter
Passengers at an airport
September 25 2017
Things always take time in Westminster's line of work, but the group is edging closer to a Middle East contract that should transform the group

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use